1. Home
  2. NLY vs MEDP Comparison

NLY vs MEDP Comparison

Compare NLY & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLY
    SELLHOLDBUYas of 5 hours ago
  • MEDP
    SELLHOLDBUYas of 5 hours ago
  • Stock Information
  • Founded
  • NLY 1996
  • MEDP 1992
  • Country
  • NLY United States
  • MEDP United States
  • Employees
  • NLY N/A
  • MEDP N/A
  • Industry
  • NLY Real Estate Investment Trusts
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • NLY Real Estate
  • MEDP Health Care
  • Exchange
  • NLY Nasdaq
  • MEDP Nasdaq
  • Market Cap
  • NLY 12.6B
  • MEDP 10.5B
  • IPO Year
  • NLY 1997
  • MEDP 2016
  • Fundamental
  • Price
  • NLY $20.11
  • MEDP $297.72
  • Analyst Decision
  • NLY Buy
  • MEDP Buy
  • Analyst Count
  • NLY 11
  • MEDP 10
  • Target Price
  • NLY $21.56
  • MEDP $373.22
  • AVG Volume (30 Days)
  • NLY 8.1M
  • MEDP 399.6K
  • Earning Date
  • NLY 04-23-2025
  • MEDP 04-21-2025
  • Dividend Yield
  • NLY 13.79%
  • MEDP N/A
  • EPS Growth
  • NLY N/A
  • MEDP 42.23
  • EPS
  • NLY 1.62
  • MEDP 12.63
  • Revenue
  • NLY $1,247,853,000.00
  • MEDP $2,109,054,000.00
  • Revenue This Year
  • NLY $333.70
  • MEDP $4.45
  • Revenue Next Year
  • NLY $0.74
  • MEDP $9.67
  • P/E Ratio
  • NLY $12.54
  • MEDP $24.12
  • Revenue Growth
  • NLY N/A
  • MEDP 11.84
  • 52 Week Low
  • NLY $17.67
  • MEDP $289.01
  • 52 Week High
  • NLY $22.11
  • MEDP $459.77
  • Technical
  • Relative Strength Index (RSI)
  • NLY 32.87
  • MEDP 34.64
  • Support Level
  • NLY $19.69
  • MEDP $289.01
  • Resistance Level
  • NLY $21.82
  • MEDP $331.24
  • Average True Range (ATR)
  • NLY 0.37
  • MEDP 9.00
  • MACD
  • NLY -0.20
  • MEDP -1.62
  • Stochastic Oscillator
  • NLY 21.93
  • MEDP 36.56

Stock Price Comparison Chart: NLY vs MEDP

NLY
MEDP
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April050100150200250300350400450500NLY VS MEDP

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use